Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication-overuse headache.

Lutz Pageler1, Irini Savidou, Volker Limmroth

  • 1Department of Neurology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany

Current Pain and Headache Reports
|November 12, 2005
PubMed
Summary

Medication-overuse headache (MOH), affecting 2-4% of the population, is often caused by common headache drugs. Withdrawal is the primary treatment, with prevention through restricted drug use and patient education being key.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study.

Annals of clinical and translational neurology·2026
Same author

MMW Fortschritte der Medizin·2025
Same author

Epidemiology of Neuralgic Amyotrophy-A Retrospective Analysis of Data From a Large German Health Insurance Company.

Muscle & nerve·2025
Same author

Increase of nitrous oxide-induced neurological disorders - a German multicenter experience.

Neurological research and practice·2025
Same author

Neuralgic Amyotrophy.

Deutsches Arzteblatt international·2024
Same author

Prehospital Levetiracetam Use in Adults With Status Epilepticus: Results of a Multicenter Registry.

Journal of clinical neurology (Seoul, Korea)·2023

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Medication-overuse headache (MOH) is a common complication of chronic headache disorders.
  • It is estimated that MOH accounts for roughly 50% of chronic daily headache (CDH) cases.

Purpose of the Study:

  • To review the causes, prevalence, pathophysiology, and treatment of medication-overuse headache.
  • To emphasize preventive strategies for medication-overuse headache.

Main Methods:

  • Literature review of epidemiologic studies and clinical trials on medication-overuse headache.
  • Analysis of the role of various anti-headache medications in the development of MOH.

Main Results:

  • Almost all anti-headache drugs, including analgesics, ergots, triptans, and combination preparations, can cause MOH.
  • Prednisone may offer short-term relief during the initial phase of withdrawal therapy.

Conclusions:

  • The pathophysiology of MOH is not fully understood.
  • Withdrawal from overused medications is the cornerstone of MOH treatment.
  • Preventing MOH through restricted anti-headache drug use and patient education is crucial for reducing its prevalence.

Related Experiment Videos